MedTrace Logo

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

NCT04232566 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-01-28

No results posted yet for this study

Summary

This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how this affects its appearance and function and ultimately insulin resistance.

Conditions

Interventions

PROCEDURE

Bariatric surgery

Evaluate liver fibrosis by elastography before gastric bypass surgery.

Sponsors & Collaborators

Principal Investigators

  • Elena Anna O De Filippis · Mayo Clinic

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-20
Primary Completion
2025-12-31
Completion
2027-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04232566 on ClinicalTrials.gov